Clinical Trials on Locally Recurrent Breast Cancer
Total 13838 results
-
Spexis AGTerminatedMetastatic Breast Cancer | Locally Recurrent Breast CancerSpain, Belgium, United States, United Kingdom, Korea, Republic of, Taiwan, Italy, Russian Federation, Czechia, France, Brazil, Argentina, Ukraine
-
Sorrento Therapeutics, Inc.CompletedMetastatic Breast Cancer | Locally Recurrent Breast CancerUnited States, Georgia, Moldova, Republic of, Romania, Serbia, Singapore, Ukraine
-
Sun Pharma Advanced Research Company LimitedWithdrawnMetastatic Breast Cancer | Locally Recurrent CancerIndia
-
Geron CorporationCompletedLocally Recurrent or Metastatic Breast CancerUnited States, Canada
-
AmgenCompletedLocally Recurrent and Metastatic Breast Cancer
-
AmgenCompletedLocally Recurrent and Metastatic Breast CancerUnited States, United Kingdom, Denmark, Poland, Belgium, Hungary, Spain, Austria, France, Australia, Netherlands, Finland, India
-
Eisai Inc.CompletedLocally Recurrent | Metastatic Breast Cancer ( HER2 Negative)United States
-
AmgenCompletedCancer | Breast Cancer | Breast Neoplasms | Metastatic Cancer | Breast Tumors | Solid Tumors | Oncology | Tumors | Metastases | Locally Recurrent and Metastatic Breast CancerUnited States, Belgium, France
-
Memorial Sloan Kettering Cancer CenterCedars-Sinai Medical CenterCompletedLocally Recurrent/Metastatic Triple Negative Breast CancerUnited States
-
Nektar TherapeuticsCompletedMetastatic Breast Cancer | Locally Recurrent Breast CancerUnited States, Spain, Korea, Republic of, Canada, United Kingdom, Germany, France, Netherlands, Belgium, Italy, Russian Federation
-
AmgenTerminatedBreast Cancer | Breast Neoplasms | Breast Tumors | Locally Recurrent and Metastatic Breast Cancer
-
Royal Marsden NHS Foundation TrustPfizer; Breast Cancer NowRecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Recurrent Breast Cancer | ER+ Breast CancerUnited Kingdom
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Vietstar Biomedical Research; MedProve IncCompletedBreast Cancer Recurrent | Breast Cancer Female | Breast Cancer MetastaticVietnam
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Vietstar Biomedical Research; MedProve IncCompletedBreast Cancer Recurrent | Breast Cancer Female | Breast Cancer MetastaticVietnam
-
University of Southern CaliforniaTerminatedRecurrent Breast Cancer | Metastastic Breast CancerUnited States
-
Korean Breast Cancer Study GroupUnknownMetastatic Breast Cancer | Recurrent Breast CancerKorea, Republic of
-
Asan Medical CenterCompletedStage IV Breast Cancer | Recurrent Breast CancerKorea, Republic of
-
Ontario Clinical Oncology Group (OCOG)Canadian Breast Cancer Research Alliance; Ontario Cancer Research NetworkCompletedMetastatic Breast Cancer | Recurrent Breast CancerCanada
-
National Cancer Institute (NCI)CompletedBreast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerCanada
-
Virginia Commonwealth UniversityEli Lilly and Company; BayerTerminatedBreast Cancer | Metastatic Breast Cancer | Recurrent Breast CancerUnited States
-
Hospital Clinic of BarcelonaRecruitingReoperative Sentinel Lymph Node Biopsy in Patients With Recurrent Ipsilateral Breast Cancer (RENATA)Recurrent Breast CancerSpain
-
Korean Breast Cancer Study GroupUnknownRecurrent Breast CancerKorea, Republic of
-
NCIC Clinical Trials GroupGlaxoSmithKlineCompletedRecurrent Breast CancerCanada
-
Dana-Farber Cancer InstituteIncyte CorporationCompletedMetastatic Breast Cancer | Recurrent Breast CancerUnited States
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Breast CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingMetastatic Breast Cancer | Advanced Malignancies | Recurrent Breast CancerChina
-
Puma Biotechnology, Inc.Not yet recruitingMetastatic Breast Cancer | Recurrent Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Daehwa Pharmaceutical Co., Ltd.CompletedRecurrent or Metastatic Breast CancerUnited States, Czechia
-
Eisai Co., Ltd.CompletedInoperable or Recurrent Breast CancerJapan
-
Sun Pharma Advanced Research Company LimitedCompletedRecurrent or Metastatic Breast CancerIndia
-
Alaunos TherapeuticsCompletedBreast Cancer Nos Metastatic RecurrentUnited States
-
Daehwa Pharmaceutical Co., Ltd.Active, not recruitingRecurrent or Metastatic Breast CancerChina, Korea, Republic of, Serbia, Bulgaria, Hungary
-
Kyowa Kirin Co., Ltd.CompletedAdvanced or Recurrent Breast CancerJapan
-
Cancer Institute and Hospital, Chinese Academy...QuestgenomicsUnknownRecurrent or Metastatic Breast CancerChina
-
Stanford UniversityNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedBreast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownAdvanced Recurrent or Metastatic Breast CancerChina
-
Introgen TherapeuticsCompletedLocally Advanced Breast Cancer (LABC)United States
-
Abramson Cancer Center at Penn MedicineRecruitingWomen With Suspected or Confirmed Recurrent Breast CancerUnited States
-
Shanghai JMT-Bio Inc.Not yet recruitingFirst-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer
-
Loyola UniversityRecruitingLocally Recurrent Prostate CancerUnited States
-
Sophiris Bio CorpCompletedLocally Recurrent Prostate CancerUnited States
-
Gregory DanielsImmunotherapy FoundationRecruitingMetastatic Melanoma | Metastatic Head and Neck Cancer | Locally Advanced Refractory/Recurrent Melanoma | Locally Advanced Refractory/Recurrent Head and Neck CancerUnited States
-
University of WashingtonMerck Sharp & Dohme LLCWithdrawnMetastatic Breast Cancer | Triple Negative Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor NegativeUnited States
-
University of UtahUnited States Department of DefenseRecruitingBreast Cancer RecurrentUnited States
-
ETOP IBCSG Partners FoundationPfizerRecruitingBreast Cancer RecurrentSwitzerland, Italy, France, Spain, Hungary, Austria
-
Odense University HospitalCompletedBreast Cancer RecurrentDenmark
-
National Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIC Breast Cancer | Adenocarcinoma of the Gastroesophageal Junction | Recurrent Breast Cancer | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Recurrent Esophageal Cancer | Stage IV Esophageal Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Metastatic Breast Carcinoma | Locally Advanced Unresectable Breast CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada